NF-κB inhibition: A double-edged sword in cancer?
- 1 April 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (6), 779-784
- https://doi.org/10.1016/j.ejca.2006.01.011
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Series Introduction: The transcription factor NF-κB and human diseaseJournal of Clinical Investigation, 2001
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- NF-κB as a Frequent Target for Immunosuppressive and Anti-Inflammatory Molecules**This article was accepted for publication on 27 September 1996.Advances in Immunology, 1997
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996
- Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.Genes & Development, 1995
- Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κBNature, 1995
- Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel familyCell, 1995
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994